From AI to Impact: How GPT Applications are Accelerating Drug Discovery [Webinar]
Causaly cofounders Yiannis Kiachopoulos and Artur Saudabayev hosted a webinar, “From AI to Impact”, in April 2023, exploring the transformative power of AI and GPT applications in early drug discovery. During this captivating session, they demonstrated how Causaly combines visual evidence with high precision knowledge graphs to answer complex research questions in mechanistic biology.
How LLMs like ChatGPT impact Causaly’s approach to biomedical knowledge discovery and acquisition
At Causaly, we stay close to the developments in the foundational natural language processing technologies and broader AI to understand where we stand with both academic and industrial state-of-the-art.